Global Bio-Pharma Logistics Market - 2021-2028

Global Bio-Pharma Logistics Market - 2021-2028

Market Overview

The global bio-pharma logistics market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Biopharmaceuticals represent some of the best accomplishments of modern science. These drugs are increasingly being used in practically all branches of medicine. They have become one of the most effective clinical treatment modalities for various diseases, including cancers and metabolic disorders. Bio-pharma logistics refer to the transportation and storage of these consignments.

Market Dynamics

The bio-pharma logistics market growth is driven by the expansion in demand for cellular therapies, vaccines, and blood products in the biopharmaceutical industry, driving the growth of the biopharmaceutical logistics market across the world. Enhancement in the production rate of biologics, hormone medications, vaccines, complex proteins, and temperature-specific byproducts requiring cold chain shipment has also witnessed significant growth in the bio-pharmaceutical logistics market.

Increased demand for temperature-sensitive pharmaceutical drugs is expected to drive growth in the forecast period.

As the pharmaceutical industry shifts its attention to biologics and cell and gene therapies, the need for more advanced storage solutions has heightened. The need for temperature monitoring in the pharmaceuticals and healthcare cold chain segment is significantly growing with temperature-sensitive products in the sector. The temperature requirement varies according to the specific pharmaceutical product. The potency of drugs or vaccines to degrade in temperature variations encountered in the supply chain is the key factor fueling the need for cold chain monitoring solutions. For instance, Recently, in September 2020, DHL Global Forwarding, an entity of DHL group, announced technology enhancements to its life sciences services division to meet the evolving pharma logistics needs, to counter the disruption caused due to COVID-19 pandemic. It launched ""New LifeTrack User Interface,"" a temperature-controlled shipment tracking portal, providing its customers with real-time analytics, digitalized standard operating procedures (SOP) information, and the lane risk assessment tool.

Growing advanced technologies to enhance operational efficiency is expected to drive growth in the forecast period.

Pharma logistics companies use advanced technologies such as IoT, autonomous vehicles, and blockchain to enhance operational efficiency. Blockchain maintains a digital ledger to maintain, record, and authenticate data, while IoT comprises a set of physical devices for communication over the internet. This technology enables biopharma companies to reduce operational transportation costs, lead time, and real-time cargo monitoring. It achieves cost savings by automating error-free processes by streamlining distribution operations. For instance, global logistics service providers such as DHL and Accenture have developed serialization prototypes with blockchain technology to track shipments across six geographies.

For instance, SkyCell offers IoT-enabled refrigerated containers specially designed for pharmaceutical products.

Improper distribution of drugs coupled with stringent regulatory inspections is likely to hamper market growth.

Improper distribution of drugs affects customer satisfaction, company reputation, and company profit. It can also disturb and produce a negative effect on public health, thereby hampering the medication processes of patients. With increasing scrutiny and inspections from the FDA, DEA and other global regulatory bodies, as well as the need to comply with industry standards such as good manufacturing practices (GMP), good distribution standards (GDP), good storage practices (GSP), and other international standards set by the World Health Organization (WHO), the pharmaceutical industry faces an overwhelming need to implement and enforce consistent security practices. These factors may hamper market growth.

COVID-19 Impact Analysis

With the COVID-19 pandemic, the trade of conventional and over-the-counter (OTC) drugs has increased globally. As governments, industry and other entities begin COVID-19 vaccine distribution efforts worldwide, cold chain management has emerged as a crucial factor for ensuring vaccine safety and effectiveness. Cold chain management entails maintaining refrigeration levels for highly temperature-sensitive coronavirus vaccines across manufacturing, storage, transportation and distribution processes.

As a result, the impact of the COVID-19 pandemic is also expected to increase the growth of the market.

Segment Analysis

The cold chain transport segment is expected to hold the largest share in this market segment.

Enhancement in the production rate of biologics, hormone medications, vaccines, complex proteins, and temperature-specific byproducts requires cold chain transport. For instance, in 2018, global sales of biotechnology medicines and biological products were estimated at more than 300 billion dollars. These high-value pharmaceutical products are mostly shipped via the cold chain across the entire distribution network worldwide.

The air transportation segment is expected to hold the largest share in this market segment.

Air transportation is the fastest way of shipping pharmaceutical products with negligible product damage, which is highly desired for transporting temperature-sensitive biologic drugs and vaccines.

Geographical Analysis

Asia Pacific region holds the largest market share of the global bio-pharma logistics market.

As Asia's healthcare systems mature, the demand for the latest biopharmaceutical medicines is soaring. However, most of these medicines are highly sensitive to temperature, as reliable cold chain services are crucial for effectively deploying biopharma across the Region.

With rising incomes and an improving reimbursement landscape, patients increasingly have the means to afford the newest and most effective biopharmaceuticals. Meanwhile, regulators are streamlining their approval processes to ensure that novel biopharmaceuticals and biosimilars are brought to market more quickly than before.

While biopharmaceutical treatment rates in Asia are still relatively low compared to the United States and Europe, the gap may undoubtedly narrow over time. The increased demand for medicines and PPE due to COVID-19 is a key factor of growth in the Region, but it is not just the current crisis driving growth. There is a rising demand for all kinds of drugs that help combat an increasing number of chronic and lifestyle-related diseases. Then there is the mounting pressure for over-the-counter medicines, such as vitamins, minerals, cough and cold drugs, and gastrointestinal and dermatology products.

Competitive Landscape

The global bio-pharma logistics market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Deutsche Post DHL, Kuehne + Nagel, DB Schenker, FedEx, UPS (Marken), Agility, DSV, Mainfreight Ltd, Movianto, Panalpina World Transport, CEVA Logistics, Shenzhen Windspeed International Forwarding Co., Ltd, Shenzhen Yucheng International Transport Co., Ltd, Sinotech Logistics Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the market globally. For instance, in September 2020: Nippon Express Co. Ltd announced that it is developing pharmaceutical supply chain networks that meet both hardware and software requirements for good distribution practices, enabling a safer and more secure supply of pharmaceuticals.

Bio-pharma Logistics Market Key Companies to Watch

UPS (Marken)

Company Overview: Marken is a wholly-owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 58 locations worldwide while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kits production. Marken’s dedicated 1,691 staff members manage 110,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries.

Key Developments: August 2020: UPS is building two giant freezer farms capable of super-cooling millions of vials of a COVID-19 vaccine, preparing for the day when it may need to deliver the medicine at high speed across the world.

Why Purchase the Report?
• Visualize the composition of the bio-pharma logistics market segmentation by type of operation, by Application highlighting the key commercial assets and players.
• Identify commercial opportunities in the bio-pharma logistics market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of bio-pharma logistics market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global bio-pharma logistics market report would provide access to an approx. 53 market data table, 42 figures and 200 pages.

Target Audience
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Market Segmentation

Global Bio-Pharma Logistics Market - By Application
• Air Shipping
• Sea Shipping
• Road Shipping
• Rail Shipping

Global Bio-Pharma Logistics Market – By Type of Operation
• Cold Chain
• Non-cold Chain

Global Bio-Pharma Logistics Market - By Region
• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• South America